Total Payments
$25,848
2024 Payments
$23.49
Companies
9
Transactions
40
Medicare Patients
2,580
Medicare Billing
$191,141
Payment Breakdown by Category
Other$22,880 (88.5%)
Food & Beverage$1,877 (7.3%)
Consulting$834.00 (3.2%)
Travel$247.34 (1.0%)
Education$10.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,880 | 6 | 88.5% |
| Food and Beverage | $1,877 | 27 | 7.3% |
| Consulting Fee | $834.00 | 2 | 3.2% |
| Travel and Lodging | $247.34 | 4 | 1.0% |
| Education | $10.24 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17,104 | 13 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $7,442 | 5 | $0 (2017) |
| Abbott Laboratories | $539.39 | 6 | $0 (2024) |
| Boston Scientific Corporation | $250.94 | 9 | $0 (2019) |
| Amarin Pharma Inc. | $135.23 | 2 | $0 (2017) |
| Medtronic Vascular, Inc. | $126.68 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $113.96 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $106.34 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $30.13 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.49 | 1 | Abbott Laboratories ($23.49) |
| 2021 | $113.96 | 1 | AstraZeneca Pharmaceuticals LP ($113.96) |
| 2020 | $386.25 | 3 | Abbott Laboratories ($386.25) |
| 2019 | $268.15 | 5 | Abbott Laboratories ($115.90) |
| 2018 | $105.58 | 4 | Boston Scientific Corporation ($75.44) |
| 2017 | $24,951 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,104) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Heart Failure | ||||||
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2020 | Abbott Laboratories | Xience V coronary stent system (Device) | Food and Beverage | In-kind items and services | $128.81 | General |
| Category: Vascular | ||||||
| 02/25/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $103.70 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/07/2020 | Abbott Laboratories | Xience V coronary stent system (Device) | Food and Beverage | In-kind items and services | $153.74 | General |
| Category: Vascular | ||||||
| 11/22/2019 | Boston Scientific Corporation | EMBLEM S ICD ELECTRODE DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: TACHY | ||||||
| 11/14/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $106.34 | General |
| Category: HBV | ||||||
| 05/29/2019 | Abbott Laboratories | TactiCath Quartz CFA Catheter (Device) | Food and Beverage | In-kind items and services | $115.90 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/12/2019 | Boston Scientific Corporation | SQ RX PULSE GENERATOR (Device) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: TACHY | ||||||
| 03/06/2019 | Boston Scientific Corporation | SQ RX PULSE GENERATOR (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: TACHY | ||||||
| 11/27/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/22/2018 | Boston Scientific Corporation | SQRX PULSE GENERATOR (Device) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: TACHY | ||||||
| 02/20/2018 | Boston Scientific Corporation | RHYTHMIA (Device) | Food and Beverage | In-kind items and services | $62.81 | General |
| Category: DIAGNOSTIC | ||||||
| 01/09/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DIABETES | ||||||
| 12/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,025.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Travel and Lodging | In-kind items and services | $99.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/30/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $100.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,685.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Travel and Lodging | In-kind items and services | $41.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/05/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,685.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/05/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Travel and Lodging | In-kind items and services | $56.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/30/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - TACHY (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: TACHY | ||||||
| 09/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,685.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Travel and Lodging | In-kind items and services | $48.87 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 21 | 2,580 | 4,010 | $1.0M | $191,141 |
Total Patients
2,580
Total Services
4,010
Medicare Billing
$191,141
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 376 | 422 | $60,780 | $37,810 | 62.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 374 | 446 | $197,184 | $35,772 | 18.1% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2020 | 114 | 822 | $81,378 | $19,571 | 24.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 111 | 184 | $71,208 | $17,685 | 24.8% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 146 | 205 | $77,022 | $11,505 | 14.9% |
| 93296 | Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days | Office | 2020 | 132 | 339 | $54,918 | $8,911 | 16.2% |
| 33208 | Insertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes | Facility | 2020 | 19 | 19 | $45,923 | $8,799 | 19.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 68 | 68 | $46,308 | $8,742 | 18.9% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Office | 2020 | 331 | 344 | $123,153 | $8,005 | 6.5% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2020 | 95 | 230 | $33,120 | $6,163 | 18.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 481 | 513 | $61,047 | $6,091 | 10.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 31 | $23,777 | $5,664 | 23.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 31 | $16,554 | $3,886 | 23.5% |
| 93295 | Remote evaluations of defibrillator up to 90 days with analysis, review and report | Office | 2020 | 38 | 109 | $28,558 | $3,660 | 12.8% |
| 0296T | External ekg recording for more than 48 hours up to 21 days | Office | 2020 | 96 | 96 | $77,280 | $2,467 | 3.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $7,033 | $1,764 | 25.1% |
| 93279 | Evaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report | Office | 2020 | 20 | 29 | $9,251 | $1,444 | 15.6% |
| 93283 | Evaluation, testing and programming adjustment of defibrillator with analysis, review and report | Office | 2020 | 13 | 17 | $6,001 | $1,400 | 23.3% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 49 | 49 | $7,698 | $1,001 | 13.0% |
| 93225 | Heart rhythm tracing of 48-hour ekg | Office | 2020 | 32 | 32 | $7,584 | $577.82 | 7.6% |
| 93290 | Evaluation of parameters of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report | Facility | 2020 | 11 | 11 | $902.00 | $223.53 | 24.8% |
About Dr. Michael Lee, MD
Dr. Michael Lee, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770512378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lee, MD has received a total of $25,848 in payments from pharmaceutical and medical device companies, with $23.49 received in 2024. These payments were reported across 40 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,880).
As a Medicare-enrolled provider, Lee has provided services to 2,580 Medicare beneficiaries, totaling 4,010 services with total Medicare billing of $191,141. Data is available for 1 year (2020–2020), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Oakland, CA
- Active Since 07/03/2006
- Last Updated 05/22/2018
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1770512378
Products in Payments
- PRADAXA (Drug) $17,104
- ELIQUIS (Drug) $7,442
- Xience V coronary stent system (Device) $282.55
- Vascepa (Drug) $135.23
- Micra (Device) $126.68
- HeartMate 3 Left Ventricular Dev (Device) $117.45
- TactiCath Quartz CFA Catheter (Device) $115.90
- FARXIGA (Drug) $113.96
- Vemlidy (Drug) $106.34
- CLINICAL TRIAL PRODUCT (Device) $78.97
- RHYTHMIA (Device) $62.81
- SQ RX PULSE GENERATOR (Device) $26.74
- CARDIOMEMS (Device) $23.49
- GENERAL - TACHY (Device) $19.60
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM (Device) $19.17
- ACCOLADE (Device) $17.08
- TOUJEO (Drug) $16.39
- IMAGEREADY MR-CONDITIONAL PACING SYSTEM (Device) $13.94
- SOLIQUA (Drug) $13.74
- SQRX PULSE GENERATOR (Device) $12.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.